Welcome to IsraPharm - Contact us at +972 7337 468 45 (Office)

Contact Us

Office Address

Weizman 14 st., Tel Aviv, Israel

Phone Number

+972 7337 46845 (Office)

Email Address

[email protected]



In Stock

Add to Wishlist
Add to Wishlist



Relapsing-remitting multiple sclerosis (RRMS) – to reduce the frequency of clinical exacerbations of the disease and reduce the risk of progression of disability.

– Clinical study results show a continuous reduction in the incidence of multiple sclerosis exacerbations and a slowdown in brain atrophy in patients receiving Gilenya continuously for 4.5 years.

– A decrease in the frequency of exacerbations of MS and improvement in MRI parameters are observed in patients already at the stage of a clinical trial.

– Study results indicate that once-daily oral Gilenya has the best combination of safety and tolerability.

Active ingredient: fingolimod

Prescription medicine.